BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2145518)

  • 1. [Down syndrome in the northeastern Netherlands; expectations and reality 1981-1986].
    Cornel MC; Tuerlings JH; Breed AS; ten Kate LP
    Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1852-5. PubMed ID: 2145518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prenatal diagnosis of Down syndrome and other autosomal trisomies in Scotland 1990 to 1994, with associated cytogenetic and epidemiological findings.
    Carothers AD; Boyd E; Lowther G; Ellis PM; Couzin DA; Faed MJ; Robb A
    Genet Epidemiol; 1999; 16(2):179-90. PubMed ID: 10030400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Down's syndrome in the Netherlands].
    Hustinx TW; Scheres JM; Geraedts JP; van Elteren P
    Tijdschr Kindergeneeskd; 1986 Aug; 54(4):101-6. PubMed ID: 2945285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.
    Cornel MC; Breed AS; Beekhuis JR; te Meerman GJ; ten Kate LP
    Hum Genet; 1993 Sep; 92(2):163-8. PubMed ID: 8370583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prenatal study of trisomy 21: triple test more efficient than age criterion].
    Mul NA; ten Velden GH
    Ned Tijdschr Geneeskd; 1996 Oct; 140(41):2032-5. PubMed ID: 8965940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
    Pescia G; Addor MC
    Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in the prevalence of Down syndrome in north-eastern France.
    Stoll C; Alembik Y; Dott B; Roth MP
    Ann Genet; 1994; 37(4):179-83. PubMed ID: 7710252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of registries in decision making in public health: the example of trisomy 21].
    Aymé S
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S82-9. PubMed ID: 8935869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of models of maternal age-specific risk for Down syndrome live births.
    Morris JK; Wald NJ; Mutton DE; Alberman E
    Prenat Diagn; 2003 Mar; 23(3):252-8. PubMed ID: 12627430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study.
    Weijerman ME; van Furth AM; Vonk Noordegraaf A; van Wouwe JP; Broers CJ; Gemke RJ
    J Pediatr; 2008 Jan; 152(1):15-9. PubMed ID: 18154890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Mutton DE; Alberman E
    Prenat Diagn; 2005 Dec; 25(12):1120-8. PubMed ID: 16231400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth prevalence of Down syndrome in Singapore from 1993 to 1998.
    Lai FM; Woo BH; Tan KH; Huang J; Lee ST; Yan TB; Tan BH; Chew SK; Yeo GS
    Singapore Med J; 2002 Feb; 43(2):070-6. PubMed ID: 11993893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome prevention program in a population with an older maternal age.
    Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
    Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trisomy 21 and maternal age: developing trends in Paris 1981-1990].
    De Vigan C; Vodovar V; Dufouil C; Goujard J
    Rev Epidemiol Sante Publique; 1992; 40(5):369-72. PubMed ID: 1480814
    [No Abstract]   [Full Text] [Related]  

  • 17. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
    Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
    J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological aspects of trisomy 21].
    Giraud F; Mattei JF
    J Genet Hum; 1975 Oct; 23 SUPPL():1-30. PubMed ID: 129536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97.
    De Vigan C; Vodovar V; Vérité V; Dehé S; Goujard J
    Prenat Diagn; 1999 Dec; 19(12):1113-8. PubMed ID: 10590427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of a Down syndrome live birth in women 45 years of age and older.
    Morris JK; De Vigan C; Mutton DE; Alberman E
    Prenat Diagn; 2005 Apr; 25(4):275-8. PubMed ID: 15849789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.